Wikidata

(Q33212983)

English

Alvimopan: an oral, peripherally acting, mu-opioid receptor antagonist for the treatment of opioid-induced bowel dysfunction--a 21-day treatment-randomized clinical trial

scientific article

In more languages

Statements

title
Alvimopan: an oral, peripherally acting, mu-opioid receptor antagonist for the treatment of opioid-induced bowel dysfunction--a 21-day treatment-randomized clinical trial (English)
1 reference
stated in
Europe PubMed Central
PubMed ID
15772912
retrieved
24 July 2017
author name string
Daniel M Paulson
series ordinal
1
1 reference
stated in
Europe PubMed Central
PubMed ID
15772912
retrieved
24 July 2017
Daniel T Kennedy
series ordinal
2
1 reference
stated in
Europe PubMed Central
PubMed ID
15772912
retrieved
24 July 2017
Roger A Donovick
series ordinal
3
1 reference
stated in
Europe PubMed Central
PubMed ID
15772912
retrieved
24 July 2017
Randall L Carpenter
series ordinal
4
1 reference
stated in
Europe PubMed Central
PubMed ID
15772912
retrieved
24 July 2017
Maryann Cherubini
series ordinal
5
1 reference
stated in
Europe PubMed Central
PubMed ID
15772912
retrieved
24 July 2017
William K Schmidt
series ordinal
9
1 reference
stated in
Europe PubMed Central
PubMed ID
15772912
retrieved
24 July 2017
Bruce Wallin
series ordinal
10
1 reference
stated in
Europe PubMed Central
PubMed ID
15772912
retrieved
24 July 2017
David Jackson
series ordinal
11
1 reference
stated in
Europe PubMed Central
PubMed ID
15772912
retrieved
24 July 2017

Identifiers

 
edit
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    Retrieved from "https://www.wikidata.org/w/index.php?title=Q33212983&oldid=1537261940"